Protagonist Therapeutics (PTGX) Stock Forecast & Price Target

PTGX$130.95-3.43 -2.55%
BiotechnologyGrowth StockHigh Quality
Compare
Market cap$8.55BEnterprise value$8.28BRevenue (TTM)$551.69MMarket position—

Score

68
Bullish
Value
34
Quality
77
Growth
93

Protagonist Therapeutics, Inc. price target

PTGX
Low$165.00
Average$177.25
High$190.00
Upside vs current price+35.4%

The average target of $177.25 is +35.4% versus the current PTGX price of $130.95.

Protagonist Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy3
Buy11
Hold0
Sell0
Strong sell0
ConsensusBuy

14 analysts cover PTGX.

Protagonist Therapeutics, Inc. EPS and revenue estimates

Published annual figures for PTGX on this page are 2026 EPS $4.69, 2027 EPS $-0.39. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$4.69$549.62M
2027$-0.39$204.70M

Is Protagonist Therapeutics, Inc. a buy or sell?

Of the 14 analysts covering Protagonist Therapeutics, Inc., 14 rate it a buy (3 strong buy and 11 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The PTGX consensus label is Buy, beside 14 buy-side ratings and 0 sell-side ratings.

The average target of $177.25 implies +35.4% versus the current price of $130.95.

The PTGX rating block is 14 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the Protagonist Therapeutics, Inc. forecast

the Protagonist Therapeutics, Inc. has a tight target cluster: $165.00 to $190.00, average $177.25.

The gap from the $130.95 price to the PTGX average is +35.4%.

The PTGX rating mix is lopsided rather than split: 14 of 14 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

The latest PTGX actions do not point one way: 1 up and 0 down.

Month by month, the PTGX average target is higher ($184.00) than the quarterly average ($176.00).

With 14 analysts on PTGX, the average is a small sample.

Protagonist Therapeutics, Inc. forecast questions

What is the PTGX price target?

The published range for PTGX is $165.00 to $190.00, with an average of $177.25. That average is +35.4% versus the current price of $130.95.

Is Protagonist Therapeutics, Inc. a buy or sell?

Of the 14 analysts covering Protagonist Therapeutics, Inc., 14 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving PTGX at 14 buy ratings, 0 holds, and 0 sells.

What is the EPS estimate for Protagonist Therapeutics, Inc.?

Analyst EPS estimates for Protagonist Therapeutics, Inc.: 2026 $4.69, 2027 $-0.39.

What is the revenue estimate for Protagonist Therapeutics, Inc.?

Analyst revenue estimates for Protagonist Therapeutics, Inc.: 2026 $549.62M, 2027 $204.70M.

How many analysts cover PTGX?

14 analysts cover PTGX. Their consensus on PTGX is Buy, across those 14.

PTGX price $130.95 -3.43 -2.55%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener